Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
05.11.2020 14:26:08

ANI Pharmaceuticals, Inc. Q3 adjusted earnings Beat Estimates

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) released a profit for third quarter that fell from the same period last year.

The company's profit came in at $0.43 million, or $0.04 per share. This compares with $3.90 million, or $0.32 per share, in last year's third quarter.

Excluding items, ANI Pharmaceuticals, Inc. reported adjusted earnings of $11.64 million or $0.97 per share for the period.

Analysts had expected the company to earn $0.88 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 3.2% to $52.98 million from $51.34 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q3): $11.64 Mln. vs. $14.79 Mln. last year. -EPS (Q3): $0.97 vs. $1.23 last year. -Analysts Estimate: $0.88 -Revenue (Q3): $52.98 Mln vs. $51.34 Mln last year.

Nachrichten zu Biosante Pharmaceuticals Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Biosante Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Biosante Pharmaceuticals Inc 53,50 1,90% Biosante Pharmaceuticals Inc